Submit an Original Article

GSK Faces Lengthy Court Battle In UK Over Diabetes Drug

From ValueWalk
January 30, 2013 - 12:02pm
Glaxosmithkline plc (ADR) (NYSE:GSK) could face a lengthy court battle against families in United Kingdom seeking compensation for damages caused by its now withdrawn diabetes drug, Avandia, according to a report from Reuters. … Express Solicitors, a law firm based inThe post GSK Faces Lengthy Court Battle In UK Over Diabetes Drug appeared first on ValueWalk.

Continue reading this article »

Share This Article:

Submit an Original Article

Wall Street Buzz

MOST POPULAR